{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:34:46Z","timestamp":1775511286333,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/ogx.0000000000000017","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T09:12:03Z","timestamp":1388740323000},"page":"39-45","source":"Crossref","is-referenced-by-count":6,"title":["An Overview of Medical Abortion for Clinical Practice"],"prefix":"10.1097","volume":"69","author":[{"given":"Amy G.","family":"Bryant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Regan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008.","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"R3-16-20210212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.contraception.2009.01.011","article-title":"Meta-analysis of 200 or 600 mg mifepristonein association with two prostaglandins for termination of early pregnancy.","volume":"80","author":"Lievre","year":"2009","journal-title":"Contraception"},{"key":"R4-16-20210212","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.","volume":"8","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"R5-16-20210212","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1471-0528.2007.01274.x","article-title":"Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion A retrospective analysis of 8678 abortions.","volume":"114","author":"Aldrich","year":"2007","journal-title":"BJOG"},{"key":"R6-16-20210212","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.09.002","article-title":"Comparing two early medical abortion regimens: mifepristonemisoprostol vs. misoprostol alone.","volume":"83","author":"Ngoc","year":"2011","journal-title":"Contraception"},{"key":"R7-16-20210212","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(07)60914-3","article-title":"Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial.","volume":"369","author":"Von Hertzen","year":"2007","journal-title":"Lancet"},{"key":"R8-16-20210212","first-page":"825","article-title":"Comparing bimanual pelvic examination to ultrasound measurement for assessment of gestational age in the first trimester of pregnancy.","volume":"47","author":"Nichols","year":"2002","journal-title":"J Reprod Med"},{"key":"R9-16-20210212","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0010-7824(86)90041-7","article-title":"The value of real time ultrasonography in first trimester termination.","volume":"33","author":"Fakih","year":"1986","journal-title":"Contraception"},{"key":"R10-16-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0010-7824(02)00316-5","article-title":"Clinicians perception of sonogram indication for mifepristone abortion up to 63 days.","volume":"66","author":"Fielding","year":"2002","journal-title":"Contraception"},{"key":"R11-16-20210212","first-page":"133","article-title":"Could American women use mifepristone-misoprostol pills safely with less medical supervision Contraception.","volume":"65","author":"Harper","year":"2002","journal-title":""},{"key":"R12-16-20210212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol.","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG"},{"key":"R13-16-20210212","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1067\/mob.2000.108230","article-title":"The roles of clinical assessment, human chorionic gonadotropin assays, and ultrasonography in medical abortion practice.","volume":"183","author":"Paul","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R14-16-20210212","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.","volume":"117","author":"Von Hertzen","year":"2010","journal-title":"BJOG"},{"key":"R15-16-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.07.013","article-title":"The combination of mifepristone and misoprostol for the termination of pregnancy.","volume":"115","author":"Faundes","year":"2011","journal-title":"Int J Gynecol Obstet"},{"key":"R16-16-20210212","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2012.10.027","article-title":"A review of evidence for safe abortion care.","volume":"88","author":"Kapp","year":"2013","journal-title":"Contraception"},{"key":"R17-16-20210212","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70 days of gestational age.","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R19-16-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","article-title":"Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases.","volume":"69","author":"Ashok","year":"2004","journal-title":"Contraception"},{"key":"R20-16-20210212","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"R21-16-20210212","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.contraception.2004.10.015","article-title":"Medical abortion at 9-13 weeks gestation: a review of 1076 consecutive cases.","volume":"71","author":"Hamoda","year":"2005","journal-title":"Contraception"},{"key":"R22-16-20210212","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/AOG.0b013e3181da0c3e","article-title":"Medical abortion at 63 to 90 days of gestation.","volume":"115","author":"Lokeland","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R23-16-20210212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curacao.","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R24-16-20210212","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1067\/mob.2000.107950","article-title":"Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.","volume":"183","author":"Newhall","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R25-16-20210212","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.contraception.2008.07.015","article-title":"Medical abortion practices: a survey of National Abortion Federation members in the United States.","volume":"78","author":"Wiegerinck","year":"2008","journal-title":"Contraception"},{"key":"R26-16-20210212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2006.11.011","article-title":"Can mifepristone medical abortion be simplified A review of the evidence and questions for future research.","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"key":"R27-16-20210212","first-page":"192","article-title":"Can women accurately assess the outcome of medical abortion based on symptoms alone Contraception.","volume":"85","author":"Jackson","year":"2012","journal-title":""},{"key":"R28-16-20210212","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2010.08.023","article-title":"Alternatives to ultrasound for follow-up after medication abortion: a systematic review.","volume":"83","author":"Grossman","year":"2011","journal-title":"Contraception"},{"key":"R29-16-20210212","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2006.08.001","article-title":"Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated.","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"key":"R30-16-20210212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0010-7824(01)00266-9","article-title":"Monitoring serum chorionic gonadotropin levels after mifepristone abortion.","volume":"64","author":"Walker","year":"2001","journal-title":"Contraception"},{"key":"R31-16-20210212","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/13625180701536300","article-title":"Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.","volume":"12","author":"Parashar","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R32-16-20210212","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion.","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"key":"R33-16-20210212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2011.11.010","article-title":"Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation.","volume":"86","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"R34-16-20210212","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2007.01.021","article-title":"Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited.","volume":"75","author":"Godfrey","year":"2007","journal-title":"Contraception"},{"key":"R36-16-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.contraception.2006.03.002","article-title":"Treatment of pain during medical abortion.","volume":"74","author":"Penney","year":"2006","journal-title":"Contraception"},{"key":"R37-16-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.contraception.2010.08.006","article-title":"Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity.","volume":"83","author":"Suhonen","year":"2011","journal-title":"Contraception"},{"key":"R38-16-20210212","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2011.12.041","article-title":"Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.","volume":"97","author":"Avraham","year":"2012","journal-title":"Fertil Steril"},{"key":"R39-16-20210212","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.contraception.2010.07.014","article-title":"Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review.","volume":"83","author":"Jackson","year":"2011","journal-title":"Contraception"},{"key":"R40-16-20210212","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.fertnstert.2008.01.084","article-title":"Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study.","volume":"91","author":"Livshits","year":"2009","journal-title":"Fertil Steril"},{"key":"R41-16-20210212","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/AOG.0b013e31829d5a33","article-title":"Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial.","volume":"122","author":"Raymond","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R42-16-20210212","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.contraception.2010.08.022","article-title":"Severity of infection following the introduction of new infection control measures for medical abortion.","volume":"83","author":"Fjerstad","year":"2011","journal-title":"Contraception"},{"key":"R43-16-20210212","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion.","volume":"361","author":"Fjerstad","year":"2009","journal-title":"NEJM"},{"key":"R44-16-20210212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.03.003","article-title":"Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale.","volume":"74","author":"Davey","year":"2006","journal-title":"Contraception"},{"key":"R45-16-20210212","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.contraception.2012.09.001","article-title":"First-trimester abortion in women with medical conditions.","volume":"86","author":"Guiahi","year":"2012","journal-title":"Contraception"},{"key":"R46-16-20210212","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mob.2003.208","article-title":"Is Rh immune globulin needed in early first-trimester abortion A review.","volume":"188","author":"Jabara","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R48-16-20210212","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3122\/jabfm.2010.04.090229","article-title":"Medical abortion: outcomes in a family medicine setting.","volume":"23","author":"Prine","year":"2010","journal-title":"J Am Board Fam Med"},{"key":"R49-16-20210212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0968-8080(09)33445-X","article-title":"Non-physician clinicians can safely provide first trimester medical abortion.","volume":"17","author":"Yarnall","year":"2009","journal-title":"Reprod Health Matters"}],"container-title":["Obstetrical &amp; Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OGX.0000000000000017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:23:40Z","timestamp":1620966220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-201401000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0000000000000017","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}